Papa, A.; Scaldaferri, F.; Covino, M.; Tursi, A.; Furfaro, F.; Mocci, G.; Lopetuso, L.R.; Maconi, G.; Bibbò, S.; Fiorani, M.;
et al. Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. Biomedicines 2022, 10, 843.
https://doi.org/10.3390/biomedicines10040843
AMA Style
Papa A, Scaldaferri F, Covino M, Tursi A, Furfaro F, Mocci G, Lopetuso LR, Maconi G, Bibbò S, Fiorani M,
et al. Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. Biomedicines. 2022; 10(4):843.
https://doi.org/10.3390/biomedicines10040843
Chicago/Turabian Style
Papa, Alfredo, Franco Scaldaferri, Marcello Covino, Antonio Tursi, Federica Furfaro, Giammarco Mocci, Loris Riccardo Lopetuso, Giovanni Maconi, Stefano Bibbò, Marcello Fiorani,
and et al. 2022. "Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study" Biomedicines 10, no. 4: 843.
https://doi.org/10.3390/biomedicines10040843
APA Style
Papa, A., Scaldaferri, F., Covino, M., Tursi, A., Furfaro, F., Mocci, G., Lopetuso, L. R., Maconi, G., Bibbò, S., Fiorani, M., Laterza, L., Mignini, I., Napolitano, D., Parisio, L., Pizzoferrato, M., Privitera, G., Pugliese, D., Schepis, T., Schiavoni, E.,
... Gasbarrini, A.
(2022). Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study. Biomedicines, 10(4), 843.
https://doi.org/10.3390/biomedicines10040843
